BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND HOXA9, HOX1, 3205, ENSG00000078399, HOX1G, P31269 AND Treatment
12 results:

  • 1. NK cell activity and methylated hoxa9 ctDNA as prognostic biomarkers in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors.
    Wen SWC; Nederby L; Andersen RF; Hansen TS; Nyhus CH; Hilberg O; Jakobsen A; Hansen TF
    Br J Cancer; 2023 Jul; 129(1):135-142. PubMed ID: 37137997
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Efficacy, Safety, and Biomarker Analysis of Neoadjuvant Camrelizumab and Apatinib in Patients With Resectable NSCLC: A Phase 2 Clinical Trial.
    Zhao J; Zhao L; Guo W; Wang S; Tao X; Li L; Mao Y; Tan F; Gao Y; Wu N; Ying J; Xue Q; Li N; Gao S; He J
    J Thorac Oncol; 2023 Jun; 18(6):780-791. PubMed ID: 36870519
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A Synthetic CPP33-Conjugated
    Yu SL; Koo H; Lee SI; Kang J; Han YH; Yeom YI; Lee DC
    Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33238593
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Trends in Outpatient Chemotherapy for Thoracic Oncology].
    Fukuda M; Yamaguchi H; Takemoto S; Senju H; Gyotoku H; Dotsu Y; Umeyama Y; Tsuchiya A; Ikeda T; Nose S; Honda T; Kobayashi K; Ishii K; Mukae H; Ashizawa K
    Gan To Kagaku Ryoho; 2020 Oct; 47(10):1461-1464. PubMed ID: 33130741
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification of MMP1 as a potential gene conferring erlotinib resistance in non-small cell lung cancer based on bioinformatics analyses.
    Zhou H; Xiang Q; Hu C; Zhang J; Zhang Q; Zhang R
    Hereditas; 2020 Jul; 157(1):32. PubMed ID: 32703314
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Recombinant cell-permeable hoxa9 protein inhibits NSCLC cell migration and invasion.
    Yu SL; Koo H; Lee HY; Yeom YI; Lee DC; Kang J
    Cell Oncol (Dordr); 2019 Jun; 42(3):275-285. PubMed ID: 30697674
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. hoxa9 methylation and blood vessel invasion in FFPE tissues for prognostic stratification of stage I lung adenocarcinoma patients.
    Lissa D; Ishigame T; Noro R; Tucker MJ; Bliskovsky V; Shema S; Beck JA; Bowman ED; Harris CC; Robles AI
    Lung Cancer; 2018 Aug; 122():151-159. PubMed ID: 30032824
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Absolute quantification of DNA methylation using microfluidic chip-based digital PCR.
    Wu Z; Bai Y; Cheng Z; Liu F; Wang P; Yang D; Li G; Jin Q; Mao H; Zhao J
    Biosens Bioelectron; 2017 Oct; 96():339-344. PubMed ID: 28525852
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Development of a multiplex methylation specific PCR suitable for (early) detection of non-small cell lung cancer.
    Nawaz I; Qiu X; Wu H; Li Y; Fan Y; Hu LF; Zhou Q; Ernberg I
    Epigenetics; 2014 Aug; 9(8):1138-48. PubMed ID: 24937636
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. hoxa9 inhibits migration of lung cancer cells and its hypermethylation is associated with recurrence in non-small cell lung cancer.
    Hwang JA; Lee BB; Kim Y; Hong SH; Kim YH; Han J; Shim YM; Yoon CY; Lee YS; Kim DH
    Mol Carcinog; 2015 Jun; 54 Suppl 1():E72-80. PubMed ID: 24817037
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [The characteristics diagnosis and treatment of hepatic metastasis of simple immature ovarian teratoma].
    Fan Q; Huang H; Lian L
    Zhonghua Fu Chan Ke Za Zhi; 2000 Oct; 35(10):613-6. PubMed ID: 11372414
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.